Company Monitoring Page for Biogen

latest headlines for company on cafepharma

The meeting that could change Alzheimer's treatment
BioSpace
Tue, 11/3/20 - 09:44 pm
Tags:
Biogen, aducanumab, Alzheimer's disease, FDA
Biogen's reprieve as critic recused from aducanumab panel, but analysts still read rejection in the tea leaves
Fierce Biotech
Tue, 11/3/20 - 10:59 am
Tags:
Biogen, aducanumab, FDA, advisory panel, Alzheimer's disease
2 Fumbles and 1 Gift in Biogen's Latest Earnings Report
Motley Fool
Wed, 10/28/20 - 10:38 am
Tags:
Biogen, earnings, Spinraza
Aducanumab’s day of reckoning approaches
EP Vantage
Fri, 10/23/20 - 10:29 am
Tags:
Biogen, earnings, aducanumab, FDA, Alzheimer's disease
Biogen is running out of safety nets
BioPharma Dive
Thu, 10/22/20 - 10:53 am
Tags:
Biogen, Vumerity, Tecfidera, Spinraza, aducanumab
Biogen finally culls MS dud opicinumab, adds SMA gene therapy to the garbage heap
Fierce Biotech
Wed, 10/21/20 - 10:58 am
Tags:
Biogen, earnings, opicinumab, MS, SMA, BIIB089
Biogen Alzheimer's Drug Headed For Unfavorable Vote, Says An Analyst's Mock Panel
Investors Business Daily
Mon, 10/19/20 - 10:53 am
Tags:
Biogen, aducanumab, Alzheimer's disease, FDA, analysts, advisory panels, mock advisory panels
Biogen teams up with gene-editing startup Scribe on ALS program
Pharmaforum
Thu, 10/8/20 - 11:09 am
Tags:
Scribe Therapeutics, Biogen, ALS, CRISPR
Biogen's all-important Alzheimer's drug enters the review gauntlet
BioPharma Dive
Tue, 09/29/20 - 11:38 pm
Tags:
Biogen, FDA, aducanumab, Alzheimer's disease
Biogen Conference Led to 20,000 COVID-19 Cases, Study Suggests
BioSpace
Tue, 08/25/20 - 09:39 pm
Tags:
Biogen, conferences, pandemic, COVID-19
Mylan launches first generic to Tecfidera in multiple sclerosis
Seeking Alpha
Wed, 08/19/20 - 09:26 am
Tags:
Mylan, generics, Tecfidera, Biogen, MS, multiple sclerosis
Biogen to Run Phase IV SMA Trial: “I Want to Optimize Their Life.”
BioSpace
Wed, 08/12/20 - 12:14 am
Tags:
Biogen, SMA, spinal muscular atrophy, Spinraza, clinical trials
Biogen nabs speedy FDA review for controversial Alzheimer’s drug
Fierce Biotech
Fri, 08/7/20 - 11:00 am
Tags:
Biogen, aducanumab, Eisai, FDA, Alzheimer's disease, priority review
Denali Therapeutics stock rockets into record territory after Biogen investment and collaboration
Marketwatch
Thu, 08/6/20 - 10:30 am
Tags:
Denali Therapeutics, Biogen, Parkinson's Disease
Biogen's last-ditch pitch for an injunction to protect Tecfidera is denied, paving way for Mylan generic
Endpoints
Fri, 07/31/20 - 10:46 am
Tags:
Biogen, Tecfidera, Mylan, generics
Biogen points to COVID-19 for disappointing drug launch
BioPharma Dive
Wed, 07/22/20 - 11:42 pm
Tags:
Biogen, Vumerity, MS, multiple sclerosis
Biogen's stock rises after big earnings beat, raised outlook
Marketwatch
Wed, 07/22/20 - 10:31 am
Tags:
Biogen, earnings
Biogen to launch Phase IV study of spinal muscular atrophy drug in post-gene therapy patients
MedCity News
Tue, 07/21/20 - 10:37 am
Tags:
Biogen, clinical trials, Spinraza, Novartis, Zolgensma, SMA, spinal muscular atrophy
10 most valuable R&D projects in the pharmaceutical industry pipeline
Beckers Hospital Review
Mon, 07/20/20 - 11:49 pm
Tags:
R&D, drug development, Eli Lilly, Novartis, Argenx, Bristol-Myers Squibb, Vir Biotechnolgy, Biogen, GSK, Iovance, Roche
Alzheimer’s catalysts round off a year dominated by Biogen
EP Vantage
Fri, 07/17/20 - 11:17 am
Tags:
Alzheimer's disease, Roche, Eli Lilly, AC Immune, Biohaven, Cortexyme, Biogen

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.